Insitro CEO Daphne Koller on machine learning in the lab We’re entering a “new era of science”—we finally have enough data and technology to truly enable better drugs for patients, says insitro CEO Daphne Koller. Read the article “‘It will be a paradigm shift’: Daphne Koller on machine learning in drug discovery”